Viewing Study NCT00282932


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-01-01 @ 7:20 PM
Study NCT ID: NCT00282932
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2006-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Detrol LA In Men With Overactive Bladder.
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module